Altimmune Inc (ALT)
6.74
0.00 (0.00%)
USD |
NASDAQ |
Nov 01, 16:00
6.70
-0.04
(-0.59%)
After-Hours: 20:00
Altimmune Market Cap: 479.02M for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 479.02M |
| October 31, 2024 | 479.02M |
| October 30, 2024 | 480.44M |
| October 29, 2024 | 523.08M |
| October 28, 2024 | 498.21M |
| October 25, 2024 | 475.46M |
| October 24, 2024 | 480.80M |
| October 23, 2024 | 477.60M |
| October 22, 2024 | 483.28M |
| October 21, 2024 | 490.39M |
| October 18, 2024 | 488.97M |
| October 17, 2024 | 482.57M |
| October 16, 2024 | 487.55M |
| October 15, 2024 | 500.34M |
| October 14, 2024 | 456.99M |
| October 11, 2024 | 447.75M |
| October 10, 2024 | 427.85M |
| October 09, 2024 | 434.24M |
| October 08, 2024 | 443.48M |
| October 07, 2024 | 433.53M |
| October 04, 2024 | 442.77M |
| October 03, 2024 | 437.09M |
| October 02, 2024 | 445.62M |
| October 01, 2024 | 447.04M |
| September 30, 2024 | 436.38M |
| Date | Value |
|---|---|
| September 27, 2024 | 459.83M |
| September 26, 2024 | 483.99M |
| September 25, 2024 | 497.50M |
| September 24, 2024 | 506.03M |
| September 23, 2024 | 511.71M |
| September 20, 2024 | 553.64M |
| September 19, 2024 | 538.01M |
| September 18, 2024 | 528.06M |
| September 17, 2024 | 538.01M |
| September 16, 2024 | 538.72M |
| September 13, 2024 | 560.04M |
| September 12, 2024 | 504.60M |
| September 11, 2024 | 509.58M |
| September 10, 2024 | 494.65M |
| September 09, 2024 | 453.43M |
| September 06, 2024 | 440.64M |
| September 05, 2024 | 454.14M |
| September 04, 2024 | 461.96M |
| September 03, 2024 | 453.43M |
| August 30, 2024 | 476.18M |
| August 29, 2024 | 469.78M |
| August 28, 2024 | 460.54M |
| August 27, 2024 | 476.18M |
| August 26, 2024 | 487.55M |
| August 23, 2024 | 493.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
23.47M
Minimum
Nov 19 2019
1.099B
Maximum
Sep 02 2022
406.57M
Average
438.14M
Median
Market Cap Benchmarks
| Eli Lilly and Co | 777.42B |
| Viking Therapeutics Inc | 8.121B |
| Amgen Inc | 171.59B |
| Avid Bioservices Inc | 655.18M |
| NovaBay Pharmaceuticals Inc | 3.664M |
Market Cap Related Metrics
| PS Ratio | 1045.85 |
| PEG Ratio | -6.699 |
| Price to Book Value | 3.140 |
| Price | 6.74 |
| Earnings Yield | -24.33% |